Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) declared a dividend on Monday, March 10th, NASDAQ Dividends reports. Shareholders of record on Monday, April 7th will be given a dividend of 0.3758 per share by the biotechnology company on Wednesday, April 23rd. The ex-dividend date of this dividend is Monday, April 7th. This is a 123.9% increase from Novozymes A/S’s previous dividend of $0.17.
Novozymes A/S Stock Up 1.1 %
Shares of NVZMY stock traded up $0.65 during trading hours on Tuesday, hitting $58.96. 10,482 shares of the company’s stock traded hands, compared to its average volume of 20,958. Novozymes A/S has a 12-month low of $52.96 and a 12-month high of $72.50. The stock has a market cap of $27.61 billion, a price-to-earnings ratio of 37.32, a PEG ratio of 3.87 and a beta of 0.91. The stock’s fifty day simple moving average is $57.04 and its two-hundred day simple moving average is $61.33.
Analysts Set New Price Targets
Separately, Barclays raised Novozymes A/S to a “strong-buy” rating in a report on Monday, November 18th.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Read More
- Five stocks we like better than Novozymes A/S
- How to Buy Cheap Stocks Step by Step
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Short Nasdaq: An Easy-to-Follow Guide
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Are Dividend Contenders? Investing in Dividend Contenders
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.